OMRT-14. Small molecule circadian clock compounds exhibit potential as a novel therapy paradigm for glioblastoma

Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor type, claiming the lives of patients within 2 years of diagnosis. The major challenges in treating GBM are largely due to the biological characteristics of the tumor and the brain and pharmacokinetics of many drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Priscilla, Hirota, Tsuyoshi, Qu, Meng, Zhang, Guoxin, Shah, Khalid, Wakimoto, Hiroaki, Kamenecka, Theodore, Solt, Laura, Rich, Jeremy, Kay, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255417/
http://dx.doi.org/10.1093/noajnl/vdab070.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255417/
http://dx.doi.org/10.1093/noajnl/vdab070.038

Ejemplares similares